Google's updated guidance clarifies that Google-Extended is not used as a ranking signal, nor does it affect search inclusion ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Vertex Pharmaceuticals today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK® ...

Vertex Minerals (ASX:VTX) has announced the identification of a fully developed two-stope block at its Reward Mine in New ...

Zacks Research bumped up Vertex Pharmaceuticals’ Q1 2027 earnings forecast by a thrilling one cent, now expecting $4.24 per ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Baron Health Care Fund retreated in the first quarter of 2025, underperforming its benchmark, the Russell 3000 Health Care ...

Learn more about whether Bitdeer Technologies Group or Vertex, Inc. is a better investment based on AAII's A+ Investor grades ...

Vertex Pharmaceuticals (VRTX) shares have climbed 22.3% year-to-date, significantly outpacing the S&P 500 and broader healthcare sector ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...